Sage Therapeutics posted phase 2 results from its Parkinson’s disease study yesterday in which it said its experimental med could help tremors, but the top-line data were met with confusion by Bio ...

Sage Therapeutics has scored another big win in the clinic. SAGE-217 triggered near-immediate, fairly durable improvements in patients with major depressive disorder (MDD), sending its stock on a tear ...

Sage, provider of cloud business management solutions, is releasing its new, cloud-first Sage Data and Analytics service integration for Sage 300 and Sage 100 in the U.S. and Canada. A powerful ...

Sage Therapeutics, Inc. (SAGE) stock remains a hold for now. The reason why I think this stock should be a "hold" rating is because it expects to report results from its phase 2b KINETIC 2 Study, ...

Sage has introduced a data and analytics product in the U.S. and Canada built around its Sage 100 and 300 accounting software. Processing Content Sage Data & Analytics (SD&A) is a business ...

PLANO, Texas--(BUSINESS WIRE)--Tyler Technologies, Inc. (NYSE: TYL) today announced it has acquired Sage Data Security, LLC, leading experts in cybersecurity. Sage offers a suite of services that ...

This type of depression, like MDD, can last many months or even longer. How long it lasts highly depends upon whether or not treatment is successful. Such treatment options might include: Hormone ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. Tyler Technologies Inc., a Texas-based information technology provider with ...

Sage, a global supplier of business management software, has announced that it has further integrated Oracle Database 11g within Sage ERP X3 in order to offer customers a comprehensive solution. Sage ...

Sage Group has admitted to a data breach which may affect hundreds of UK business customers. Over the weekend, the accounting software company revealed that the network compromise was caused by ...